Second Sight Medical Products Inc. (NASDAQ:EYES) went up by 1.71% during the previous trading session, and it is maintaining the win ahead of Monday’s trading session. The share price of the Medical Devices giant went up by $1.19 to trade ended Monday trading at $1.17. This is up from the $1.17 price recorded on Friday’s trading session. Thanks to this latest performance, EYES is closer to the higher price 52-week target of $10.00 and further from the lowest price target of $10.00. Its performance from the start of the year has also been negative, with EYES down by -79.95% year-to-date.
Second Sight Medical Products Inc. (EYES) started the day trading at $1.16 and recorded an intraday high of $1.27. It also recorded an intraday low of $1.1 during Monday’s trading session. Second Sight Medical Products Inc. is a very active stock that recorded a trading volume that is more than 11.76% of the average daily trading volume on Monday. The stock’s trading volume on Monday was 981244, which is more than 11.76 of the total average daily trading volume of 865.86K.
Second Sight Medical Products Inc. (NASDAQ:EYES) 2020 Performance Impressive
The increase in EYES’s stock price on Monday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of EYES currently stands at $8.96, which is higher than the current trading price of the stock by 86.72%. However, EYES’s current trading price is -67.61% lower than the 52-week low price of $0.71. In terms of trading volume, Second Sight Medical Products Inc. currently experienced healthy participation during the last trading session. 981244 shares of Second Sight Medical Products Inc. were traded on the stock exchange on Monday, which is more than 11.76% of the 865.86K average trading volume of the stock.
The performance of the stock has been positive over the past year. EYES’s performance over the past one year has seen it plunge by -79.00%, while the stock has gone down by -80.78% in the last six months. The quarterly performance of EYES currently stands at -56.73%, and it is up by 28.51% in the last month. The only negative figure was from the weekly performance, which currently reads -5.56%. At the time of writing EYES’s report, the company has a total market cap of $25.63M, making it one of the largest publicly-traded companies in the world.Second Sight Medical Products Inc. also has over 112 employees all over the world.
EYES Insider Activities
For Second Sight Medical Products Inc., insiders hold 3.80% of all company shares. The insider transactions over the past six months are up by 0.50%. During that period, insiders bought 11,689 shares in 3 transactions. In that same period, insiders sold 7,092 of their shares in 4 transactions. After these transactions, insiders at Second Sight Medical Products Inc. now hold 6.74M shares, which is over 22.66% of the total company stocks. Institutional investors currently hold a large chunk of the EYES shares, as they control 43.05% of the company’s total stock.
EYES Fundamental Analysis
For Second Sight Medical Products Inc., the stock’s diluted earnings per share (EPS) stands at -2.34. In the coming year, analysts expect the EPS to be -1.40. The stock’s EPS growth this year is 46.00%, 27.30% in the previous five years. In terms of revenue, Second Sight Medical Products Inc.’s quarterly sales (YOY) is shrinking at -0.41, which is lower than the average annual revenue of 27.30% over the past half a decade.
The Return on Investment (ROI) on Second Sight Medical Products Inc.’s stock currently stands at -465.10%. The gross margin of the company is 36.30%.
At the moment, Second Sight Medical Products Inc.’s Total Debt to Equity ratio stands at 0.00, and they have a long-term Debt to Equity ratio of 0.00.
EYES Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of EYES currently stands at 12.97%, while the SMA50 is -2.39%. The biggest one is the SMA200, which is currently reading -73.78% ahead of Monday’s trading session. The Relative Strength Index of this stock is 51.25.